Literature DB >> 8082848

Immunological parameters in patients with epilepsy.

S Bostantjopoulou1, O Hatzizisi, O Argyropoulou, S Andreadis, K Deligiannis, M Kantaropoulou, A Kazis, G Kyrazis, K Routsonis.   

Abstract

Various immunological parameters (IgA, IgG, IgM serum levels, C3 and C4 complement components and T and B lymphocytes and T-lymphocyte subsets) were determined in 50 patients with epilepsy (20 without medication, 15 on carbamazepine and 15 on valproate) and in 20 controls. The epileptic group had fewer CD4 and more CD8 lymphocytes, while the CD4/CD8 ratio was lower; the levels of IgG and IgM were increased and C4 complement component was also decreased. Patients without medication showed all the above mentioned abnormalities. Patients on carbamazepine had a lower CD4/CD8 ratio, increased IgG and IgM levels and decreased C4 complement component while patients on valproate had more CD8 lymphocytes, a lower CD4/CD8 ratio, increased levels of IgM and decreased C4 complement component. Our results indicate that there is a defective immune mechanism in epileptic patients modified by treatment.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8082848

Source DB:  PubMed          Journal:  Funct Neurol        ISSN: 0393-5264


  4 in total

Review 1.  Future prospects for the drug treatment of epilepsy.

Authors:  A Nicolson; J P Leach
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

2.  Serum cortisol, immunoglobulins and some complements among depressed patients.

Authors:  Hussein Kadhem Al-Hakeim
Journal:  Indian J Clin Biochem       Date:  2008-03-06

3.  Immunoglobulins in children with epilepsy: the Dutch Study of Epilepsy in Childhood.

Authors:  P M C Callenbach; C M Jol-Van Der Zijde; A T Geerts; W F M Arts; C A Van Donselaar; A C B Peters; H Stroink; O F Brouwer; M J D Van Tol
Journal:  Clin Exp Immunol       Date:  2003-04       Impact factor: 4.330

4.  Intravenous immunoglobulins for epilepsy.

Authors:  JinSong Geng; JianCheng Dong; Youping Li; HengJian Ni; Kui Jiang; Li Li Shi; GuoHua Wang
Journal:  Cochrane Database Syst Rev       Date:  2019-12-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.